[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:b-acute-lymphoblastic-leukemia-bcr-abl1-like":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":24,"states":25},"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like",2,1,[8,16],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06207123","A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed\u002FRefractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)",[12],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:16:31.714843Z","2026-05-05T02:43:27.636845Z",{"nct_id":17,"title":18,"phases":19,"status":21,"updated_at":22,"content_modified":23},"NCT05157971","Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell Acute Lymphoblastic Leukemia",[20],"Phase 1","ACTIVE_NOT_RECRUITING","2026-08-03T01:57:10.726985Z","2026-05-05T02:43:27.672886Z",[],[]]